All Stories

  1. The Effects of APOE4 on Mitochondrial Dynamics and Proteins in vivo
  2. Differential Effects of apoE4 and Activation of ABCA1 on Brain and Plasma Lipoproteins
  3. ABCA1 Agonist Reverses the ApoE4-Driven Cognitive and Brain Pathologies
  4. Reversal of ApoE4-Driven Brain Pathology by Vascular Endothelial Growth Factor Treatment
  5. THE NOVEL APOE4 THERAPEUTIC CS6253 PENETRATES THE BLOOD BRAIN BARRIER, UPREGULATES THE ABCA1 TRANSPORTER AND PREVENTS ALZHEIMER’S DISEASE PATHOGENESIS
  6. An Anti-apoE4 Specific Monoclonal Antibody Counteracts the Pathological Effects of apoE4 In Vivo
  7. Impaired Autophagy in APOE4 Astrocytes
  8. Correction of ApoE4 dysfunction and reversal of Alzheimer’s disease phenotype and cognition in ApoE4 target replacement mice by cogpepb, an abca1 agonist peptide derived from the lipid binding segment of ApoE
  9. VEGF Mediates ApoE4-Induced Neovascularization and Synaptic Pathology in the Choroid and Retina
  10. COGPEP™, AN APOE-DERIVED ABCA1 AGONIST PEPTIDE, REVERSES ALZHEIMER'S DISEASE PHENOTYPE IN HUMAN APOE4 REPLACEMENT MICE
  11. Focusing on ApoE: a viable strategy for Alzheimer therapy